Glutamate toxicity in chronic neurodegenerative disease

Progress in Brain Research

Volumn 116, Issue , 1998, Pages 331-347

  Lancelot, E ^a   Beal, M F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 7 CHLOROKYNURENIC ACID; 7 NITROINDAZOLE; AMINO ACID RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; BUDIPINE; CARBIDOPA PLUS LEVODOPA; DIHYDROLIPOATE; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IDEBENONE; LAMOTRIGINE; MALONIC ACID; MEMANTINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; RILUZOLE; SCAVENGER; SODIUM CHANNEL BLOCKING AGENT; UBIDECARENONE;

BRAIN METABOLISM; CALCIUM BINDING; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; DEGENERATIVE DISEASE; DRUG RESPONSE; HUMAN; NERVE CELL NECROSIS; NERVE CELL STIMULATION; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; REVIEW;

EID: 0031765270     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0079-6123(08)60446-x     Document Type: Review

References (188)

1. R.L. Albin J.T. Greenamyre Alternative excitotoxic hypotheses Neurology 42 1992 733 738
2. H. Allaoua I. Chaudieu C. Krieger P. Boska A. Privat R. Quirion Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients Brain Res. 579 1992 169 172
3. N.J. Anegawa D.R. Lynch T.A. Verdoorn D.B. Pritchett Transfection of N -methyl-D-aspartate receptors in a nonneuronal cell line leads to cell death J. Neurochem. 64 1995 2004 2012
4. G.W. Arendash W.J. Millard A.J. Dunn E.M. Meyer Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat Science 238 1987 952 956
5. P. Barneoud M. Mazadier J.M. Miquet S. Parmentier P. Dubedat A. Doble A. Boireau Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat Neuroscience 74 1996 971 983
6. M.F. Beal Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31 1992 119 130
7. M.F. Beal N.W. Kowall D.W. Ellison M.F. Mazurek K.J. Swartz J.B. Martin Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid Nature 321 1986 168 171
8. M.F. Beal W.R. Matson K.J. Swartz P.H. Gamache E.D. Bird Kynurenine pathway measurements in Huntington's disease striatum: Evidence for reduced formation of kynurenic acid J. Neurochem. 55 1990 1327 1339
9. M.F. Beal R.J. Ferrante K.J. Swartz N.W. Kowall Chronic quinolinic acid lesions in rats closely resemble Huntington's disease J. Neurosci. 11 1991 1649 1659
10. M.F. Beal E. Brouillet B. Jenkins R. Henshaw B. Rosen B.T. Hyman Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate J. Neurochem. 61 1993 1147 1150
11. M.F. Beal E. Brouillet B.G. Jenkins R.J. Ferrante N.W. Kowall J.M. Miller E. Storey R. Srivastava B.R. Rosen B.T. Hyman Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid J. Neurosci. 13 1993 4181 4192
12. J.S. Beckman Oxidative damage and tyrosine nitration from peroxynitrite Chem. Res. Toxicol. 9 1996 836 844
13. J.S. Beckman T.W. Beckman J. Chen P.A. Marshall B.A. Freeman Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide Proc. Natl. Acad. Sci. USA 87 1990 1620 1624
14. A. Benazzouz T. Boraud P. Dubedat A. Boireau J.M. Stutzmann C. Gross Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: A pilot study Eur. J. Pharmacol. 284 1995 299 307
15. G. Bensimon L. Lacomblez Meiniger V A controlled trial of riluzole in amyotrophic lateral sclerosis N. Engl. J. Med. 330 1994 585 591
16. A. Boireau P. Dubedat F. Bordier C. Peny J.M. Miquet G. Durand M. Meunier A. Doble Riluzole and experimental parkinsonism: Antagonism of MPTP-induced decrease in central dopamine levels in mice Neuroreport 5 1994 2657 2660
17. S.C. Bondy C.P. LeBel The relationship between excitotoxicity and oxidative stress in the central nervous system Free Rad. Biol. Med. 14 1993 633 642
18. D.S. Bredt S.H. Snyder Nitric oxide, a novel neuronal messenger Neuron 8 1992 3 11
19. E. Brouillet B.G. Jenkins B.T. Hyman R.J. Ferrante N.W. Kowall R. Srivastava D. Samanta Roy B.R. Rosen M.F. Beal Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid J. Neurochem. 60 1993 356 359
20. E. Brouillet P. Hantraye R.J. Ferrante R. Dolan A. Leroy-Willig N.W. Kowall M.F. Beal Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates Proc. Natl. Acad. Sci. USA 92 1995 7105 7109
21. N. Burnashev R. Schoepfer H. Monyer J.P. Ruppersberg W. Günther P.H. Seeburg B. Sakmann Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor Science 257 1992 1415 1419
22. C. Cazevieille A. Muller F. Meynier C. Bonne Superoxide and nitric oxide cooperation in hypoxia/reoxygenation-induced neuron injury Free Rad. Biol. Med. 14 1993 389 395
23. C. Cazevieille A. Muller F. Meynier N. Dutrait C. Bonne Protection by prostaglandins from glutamate toxicity in cortical neurons Neurochem. Int. 24 1994 395 398
24. D.T. Chalmers D. Dewar D.I. Graham D.N. Brooks J. McCulloch Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type Proc. Natl. Acad. Sci. USA 87 1990 1352 1356
25. B. Cheng M.P. Mattson NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis Neuron 1 1991 1031 1041
26. D.W. Choi Ionic dependence of glutamate neurotoxicity J. Neurosci. 7 1987 369 379
27. H.S. Chow J.J. Lynch III K. Rose D.W. Choi Trolox attenuates cortical neuronal injury induced by iron. ultraviolet light, glucose deprivation, or AMPA Brain Res. 639 1994 102 108
28. A. Copani J.Y. Koh C.W. Cotman β-amyloid increases neuronal susceptibility to injury by glucose deprivation Neuroreport 2 1991 763 765
29. C.W. Cotman A.C. Foster T.H. Lanthorn Overview of glutamate as a neurotransmitter Adv. Biochem. Psychopharmacol. 27 1981 1 27
30. J.T. Coyle R. Schwarcz Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea Nature 263 1976 244 246
31. J.T. Coyle P. Puttfarcken Oxidative stress, glutamate, and neurodegenerative disorders Science 262 1993 689 695
32. M. Culcasi M. Lafon-Cazal S. Pietri J. Bockaert Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons J. Biol. Chem. 269 1994 12589 12593
33. V.L. Dawson T.M. Dawson E.D. London D.S. Bredt S.H. Snyder Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures Proc. Natl. Acad. Sci. USA 88 1991 6368 6371
34. V.L. Dawson T.M. Dawson D.A. Bartley G.R. Uhl S.H. Snyder Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures J. Neurosci. 13 1993 2651 2661
35. C. Demerlé-Pallardy M.O. Lonchampt P.E. Chabrier P. Braquet Absence of implication of L-arginine/nitric oxide pathway on neuronal cell injury induced by L-glutamate or hypoxia Biochem. Biophys. Res. Commun. 181 1991 456 464
36. M.C. Difazio Z. Hollingsworth A.B. Young J.B. Penney Jr. Glutamate receptors in the substantia nigra of Parkinson's disease brains Neurology 42 1992 402 406
37. K.Q. Do P.L. Herrling P. Streit W.A. Turski M. Cuenod In vitro release and electrophysiological effects in situ of homocysteic acid, an endogenous N -methyl-(D)-aspartic acid agonist, in the mammalian striatum J. Neurosci. 6 1986 2226 2234
38. J.C. Drapier J.B. Hibbs Jr. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells J. Immunol. 140 1988 2829 2838
39. J.M. Dubinsky S.M. Rothman Intracellular calcium concentrations during “chemical hypoxia” and excitotoxic neuronal injury J. Neurosci. 11 1991 2545 2551
40. L.L. Dugan S.L. Sensi L.M.T. Canzoniero S.D. Handran S.M. Rothman T.S. Lin M.P. Goldberg D.W. Choi Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N -methyl-D-aspartate J. Neurosci. 15 1995 6377 6388
41. A. Dumuis M. Sebben L. Haynes J.P. Pin J. Bockaert NMDA receptors activate the arachidonic acid cascade system in striatal neurons Nature 336 1988 68 70
42. J.A. Dykens A. Stern E. Trenkner Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury J. Neurochem. 49 1987 1222 1228
43. J. Egebjerg B. Bettler I. Hermans-Borgmeyer S. Heinemann Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA Nature 351 1991 745 748
44. S. Eimerl M. Schramm The quantity of calcium that appears to induce neuronal death J. Neurochem. 62 1994 1223 1226
45. J.H. Eubanks R.S. Puranam N.W. Kleckner B. Bettler S.F. Heinemann J.O. McNamara The gene encoding the glutamate receptor subunit GluR5 is located on human chromosome 21q21.1–22.1 in the vicinity of the gene for familial amyotrophic lateral sclerosis Proc. Natl. Acad. Sci. USA 90 1993 178 182
46. A. Favit F. Nicoletti U. Scapagnini P.L. Canonico Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration J. Cereb. Blood Flow Metab. 12 1992 638 645
47. A. Frandsen A. Schousboe Excitatory amino acid-mediated cytotoxicity and calcium homeostasis in cultured neurons J. Neurochem. 60 1993 1202 1211
48. D.M. Frim T.A. Uhler M.P. Short Z.D. Ezzedine M. Klagsbrun X.O. Breakefield O. Isacson Effect of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions Neuroreport 4 1993 367 370
49. D.M. Frim J. Simpson T.A. Uhler M.P. Short S.R. Bossi X.O. Breakefield O. Isacson Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF J. Neurosci. Res. 35 1993 452 458
50. H. Fujisawa D. Dawson S.E. Browne K.B. MacKay R. Bullock J. McCulloch Pharmacological modification of glutamate neurotoxicity in vivo Brain Res. 629 1993 73 78
51. J.M. Galasso T.J. Bazzett J.B. Becker R.L. Albin Synergistic effect of intrastriatal co-administration of L-NAME and quinolinic acid Neuroreport 6 1995 1505 1508
52. W.R. Galpern R.T. Matthews M.F. Beal O. Isacson NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease Neuroreport 7 1996 2639 2642
53. G. Garthwaite J. Garthwaite Amino acid neurotoxicity: Intracellular sites of calcium accumulation associated with the onset of irreversible damage to rat cerebellar neurones in vitro Neurosci. Lett. 71 1986 53 58
54. G. Garthwaite F. Hajós J. Garthwaite Ionic requirements for neurotoxic effects of excitatory amino acid analogues in rat cerebellar slices Neuroscience 18 1986 437 447
55. M.Y.T. Globus R. Prado J. Sanchez-Ramos W. Zhao W.D. Dietrich R. Busto M.D. Ginsberg Dual role for nitric oxide in NMDA-mediated toxicity in vivo J. Cereb. Blood Flow Metab. 15 1995 904 913
56. J.T. Greenamyre M. Garcia-Osuna J.G. Greene The endogenous cofactors, thioctic acid and dihydrolipoic acid, are neuroprotective against NMDA and malonic acid lesions of striatum Neurosci. Lett. 171 1994 17 20
57. J.G. Greene R.H.P. Porter R.V. Eller J.T. Greenamyre Inhibition of succinate dehydrogenase by malonic acid produces an “excitotoxic” lesion in rat striatum J. Neurochem. 61 1993 1151 1154
58. J.G. Greene J.T. Greenamyre Exacerbation of NMDA, AMPA, and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate J. Neurochem. 64 1995 2332 2338
59. J.G. Greene J.T. Greenamyre Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate J. Neurochem. 64 1995 430 436
60. P.G. Gunasekar A.G. Kanthasamy J.L. Borowitz G.E. Isom NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: Implication for cell death J. Neurochem. 65 1995 2016 2021
61. K.A. Haberny S. Pou C.U. Eccles Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis Neurosci. Lett. 146 1992 187 190
62. J.S. Hahn E. Aizenman S.A. Lipton Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+ Toxicity is blocked by the N -methyl-D-aspartate antagonist MK-801 Proc. Natl. Acad. Sci. USA 85 1988 6556 6560
63. E.D. Hall P.A. Yonkers J.M. McCall J.M. Braughler Effects of the 21-aminosteroid U74006F on experimental head injury in mice J. Neurosurg. 68 1988 456 461
64. B. Hammer W.D. Parker Jr. J.P. Bennett Jr. NMDA receptors increase OH radicals in vivo by using nitric oxide synthase and protein kinase C Neuroreport 5 1993 72 74
65. P. Hantraye D. Riche M. Mazire O. Isacson A primate model of Huntington's disease: Behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon Exp. Neurol. 108 1990 91 104
66. P. Hantraye E. Brouillet R. Ferrante S. Palfi R. Dolan R.T. Matthews M.F. Beal Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons Nat. Med. 2 1996 1017 1021
67. D.M. Hartley M.C. Kurth L. Bjerkness J.H. Weiss D.W. Choi Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration J. Neurosci. 13 1993 1993 2000
68. T. Hayashi Effects of sodium glutamate on the nervous system Keio J. Med. 3 1954 183 192
69. R. Henshaw B.G. Jenkins J.B. Schulz R.J. Ferrante N.W. Kowall B.R. Rosen M.F. Beal Malonate produces striatal lesions by indirect NMDA receptor activation Brain Res. 647 1994 161 166
70. A. Herb N. Burnashev P. Werner B. Sakmann W. Wisden P.H. Seeburg The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits Neuron 8 1992 775 785
71. S.J. Hewett J.A. Corbett M.L. McDaniel D.W. Choi Inhibition of nitric oxide formation does not protect murine cortical cell cultures from N -methyl-D-aspartate neurotoxicity Brain Res. 625 1993 337 341
72. M. Hollmann A. O'Shea-Greenfield S.W. Rogers S. Heinemann Cloning by functional expression of a member of the glutamate receptor family Nature 342 1989 643 648
73. M. Hollmann M. Hartley S. Heinemann Ca2- permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition Science 252 1991 851 853
74. R.I. Hume R. Dingledine S.F. Heinemann Identification of a site in glutamate receptor subunits that controls calcium permeability Science 253 1991 1028 1031
75. Y. Ihara R. Namba S. Kuroda T. Sato T. Shirabe Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q10 and idebenone J. Neurol. Sci. 90 1989 263 271
76. H. Ischiropoulos L. Zhu J. Chen M. Tsai J.C. Martin C.D. Smith J.S. Beckman Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase Arch. Biochem. Biophys. 298 1992 431 437
77. Y. Izumi A.M. Benz D.B. Clifford C.F. Zorumski Nitric oxide inhibitors attenuate N -methyl-D-aspartate excitotoxicity in rat hippocampal slices Neurosci. Lett. 135 1992 227 230
78. B.G. Jenkins W.J. Koroshetz M.F. Beal B.R. Rosen Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy Neurology 43 1993 2689 2695
79. S.A. Jones-Humble P.F. Morgan B.R. Cooper The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's disease Life Sci. 54 1994 245 252
80. K. Keinänen W. Wisden B. Sommer P. Werner A. Herb T.A. Verdoorn B. Sakmann P.H. Seeburg A family of AMPA-selective glutamate receptors Science 249 1990 556 560
81. P.B. Kirschner R. Henshaw J. Weise V. Trubetskoy S. Finkelstein J.B. Schulz M.F. Beal Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats J. Cereb. Blood Flow Metab. 15 1995 619 623
82. P.B. Kirschner B.G. Jenkins J.B. Schulz S.P. Finkelstein R.T. Matthews B.R. Rosen M.F. Beal NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals Brain Res. 713 1996 178 185
83. T. Klockgether L. Turski NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats Ann. Neurol. 28 1990 539 546
84. T. Klockgether L. Turski Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia Ann. Neurol. 34 1993 585 593
85. T. Klockgether P. Jacobson P.A. Löschmann L. Turski The antiparkinsonian agent budipine is an N -methyl-D-aspartate antagonist J. Neural Transm. Park. Dis. Dement. Sect. 5 1993 101 106
86. J.Y. Koh L.L. Yang C.W. Cotman β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage Brain Res. 533 1990 315 320
87. H. Kollegger G.J. McBean K.F. Tipton Reduction of striatal N -methyl-D-aspartate toxicity by inhibition of nitric oxide synthase Biochem. Pharmacol. 45 1993 260 264
88. C. Krieger R. Wagey C. Shaw Amyotrophic lateral sclerosis: Quantitative autoradiography of [3H]MK-801/NMDA binding sites in spinal cord Neurosci. Lett. 159 1993 191 194
89. T. Kutsuwada N. Kashiwabuchi H. Mori K. Sakimura E. Kushiya K. Araki H. Meguro H. Masaki T. Kumanishi M. Arakawa M. Mishina Molecular diversity of the NMDA receptor channel Nature 358 1992 36 41
90. N.S. Kwon D.J. Stuehr C.F. Nathan Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide J. Exp. Med. 174 1991 761 767
91. M. Lafon-Cazal S. Pietri M. Culcasi J. Bockaert NMDA-dependent superoxide production and neurotoxicity Nature 364 1993 535 537
92. Lancelot M.L., Revaud R.G., Boulu M., Plotkine J., Callebert 1997 α-phenyl- N - tert -butylnitrone attenuates excitotoxicity in rat striatum by preventing hydroxyl radical accumulation. Free Rad. Biol. Med. in press.
93. K.W. Lange P.A. Löschmann E. Sofic M. Burg R. Horowski K.T. Kalveram H. Wachtel P. Riederer The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates Naunyn-Schmiedeberg's Arch. Pharmacol. 348 1993 586 592
94. M. Lepoivre F. Fieschi J. Coves L. Thelander M. Fontecave Inactivation of ribonucleotide reductase by nitric oxide Biochem. Biophys. Res. Commun. 179 1991 442 448
95. M. Lerner-Natoli G. Rondouin F. de Bock J. Bockaert Chronic NO synthase inhibition fails to protect hippocampal neurones against NMDA toxicity Neuroreport 3 1992 1109 1112
96. S.A. Lipton P.A. Rosenberg Excitatory amino acids as a final common pathway for neurologic disorders N. Engl. J. Med. 330 1994 613 622
97. D.R. Lucas J.P. Newhouse The toxic effect of sodium L-glutamate on the inner layers of the retina AMA Arch. Ophtalmol. 58 1957 193 201
98. M.D. Majewska J.A. Bell Ascorbic acid protects neurons from injury induced by glutamate and NMDA Neuroreport 1 1990 194 196
99. S. Malessa P.N. Leigh O. Bertel E. Sluga O. Hornykiewicz Amyotrophic lateral sclerosis: Glutamate dehydrogenase and transmitter amino acids in the spinal cord J. Neuro. Neurosurg. Psych. 54 1991 984 988
100. W.F. Maragos F.S. Silverstein Inhibition of nitric oxide synthase activity attenuates malonate lesions in rats J. Neurochem. 64 1995 2362 2365
101. R.T. Matthews L. Yang M.F. Beal S-met-hylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity Exp. Neurol. 143 1997 282 286
102. M.P. Mattson B. Rychlik Glia protect hippocampal neurons against excitatory amino acid-induced degeneration: Involvement of fibroblast growth factor Int. J. Dev. Neurosci. 8 1990 399 415
103. M.P. Mattson B. Cheng D. Davis K. Bryant I. Lieberburg R.E. Rydel β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity J. Neurosci. 12 1992 376 389
104. M.P. Mattson M.A. Lovell K. Furukawa W.R. Markesbery Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase anti-oxidant enzyme activities in hippocampal neurons J. Neurochem. 65 1995 1740 1751
105. E.G. McGeer P.L. McGeer Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids Nature 263 1976 517 519
106. E.G. McGeer S.G. Zhu Lamotrigine protects against kainate but not ibotenate lesions in rat striatum Neurosci. Lett. 112 1990 348 351
107. H. Meguro H. Mori K. Araki E. Kushiya T. Kutsuwada M. Yamazaki T. Kumanishi M. Arakawa K. Sakimura M. Mishina Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs Nature 357 1992 70 74
108. R.L. Michaels S.M. Rothman Glutamate neurotoxicity in vitro: Antagonist pharmacology and intracellular calcium concentrations J. Neurosci. 10 1990 283 292
109. D. Milani D. Guidolin L. Facci T. Pozzan M. Buso A. Leon S.D. Skaper Excitatory amino acidinduced alterations of cytoplasmic free Ca2+ in individual cerebellar granule neurons: Role in neurotoxicity J. Neurosci. Res. 28 1991 434 441
110. B. Miller M. Sarantis S.F. Traynelis D. Attwell Potentiation of NMDA receptor currents by arachidonic acid Nature 355 1992 722 725
111. C. Moncada D. Lekieffre B. Arvin B. Meldrum Effect of NO synthase inhibition on NMDA- and ischaemia-induced hippocampal lesions Neuroreport 3 1992 530 532
112. H. Monyer D.M. Hartley D.W. Choi 21-aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures Neuron 5 1990 121 126
113. H. Monyer R. Sprengel R. Schoepfer A. Herb M. Higuchi H. Lomeli N. Burnashev B. Sakmann P.H. Seeburg Heteromeric NMDA receptors: Molecular and functional distinction of subtypes Science 256 1992 1217 1221
114. K. Moriyoshi M. Masu T. Ishii R. Shigemoto N. Mizuno S. Nakanishi Molecular cloning and characterization of the rat NMDA receptor Nature 354 1991 31 37
115. T.H. Murphy R.L. Schnaar J.T. Coyle Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake FASEB J. 4 1990 1624 1633
116. S. Nakanishi Molecular diversity of glutamate receptors and implications for brain function Science 258 1992 597 603
117. N. Nakao E.M. Grasbon-Frodl H. Widner P. Brundin Antioxidant treatment protects striatal neurons against excitotoxic insults Neuroscience 73 1996 185 200
118. T. Nguyen D. Brunson C.L. Crespi B.W. Penman J.S. Wishnok S.R. Tannenbaum DNA damage and mutation in human cells exposed to nitric oxide in vitro Proc. Natl. Acad. Sci. USA 89 1992 3030 3034
119. F. Nicoletti V. Bruno A. Copani G. Casabona T. Knöpfel Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders? Trends Neurol. Sci. 19 1996 267 271
120. A. Novelli J.A. Reilly P.G. Lysko R.C. Henneberry Glutamate becomes neurotoxic via the N -methyl-D-aspartate receptor when intracellular energy levels are reduced Brain Res. 451 1988 205 212
121. K. Nozaki S.P. Finklestein M.F. Beal Delayed administration of basic fibroblast growth factor protects against N -methyl-D-aspartate neurotoxicity in neonatal rats Eur. J. Pharmacol. 232 1993 295 297
122. N. Ogawa K.I. Tanaka M. Asanuma M. Kawai T. Masumizu M. Kohno A. Mori Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro Brain Res. 657 1994 207 213
123. J.W. Olney O.L. Ho V. Rhee Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system Exp. Brain Res. 14 1971 61 76
124. S. Orrenius D.J. McConkey G. Bellomo P. Nicotera Role of Ca2+ in toxic cell killing Trends Pharmacol. Sci. 10 1989 281 285
125. D. Otto K. Unsicker Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice J. Neurosci. 10 1990 1912 1921
126. C.K. Park E.D. Hall Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia Brain Res. 645 1994 157 163
127. C.G. Parsons R. Gruner J. Rozental J. Millard D. Lodge Patch clamp studies on the kinetics and selectivity of N -methyl-D-aspartate receptor antagonism by memantine (1-amino-3, 5-dimethyladamantan) Neuropharmacology 32 1993 1337 1350
128. P.J. Pauwels J.E. Leysen Blockade of nitric oxide formation does not prevent glutamate-induced neurotoxicity in neuronal cultures from rat hippocampus Neurosci. Lett. 143 1992 27 30
129. R.C.A. Pearson M.M. Esiri R.W. Hiorns G.K. Wilcock T.P.S. Powell Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease Proc. Natl. Acad. Sci. USA 82 1985 4531 4534
130. Pellock 1994 Clinical efficacy of lamotrigine as an antiepileptic drug. Neurology (Suppl. 8): 29–35.
131. J.W. Phillis S. Sen X. Cao Amflutizole, a xanthine oxidase inhibitor, inhibits free radical generation in the ischemic/reperfused rat cerebral cortex Neurosci. Lett. 169 1994 188 190
132. A. Plaitakis J.T. Caroscio Abnormal glutamate metabolism in amyotrophic lateral sclerosis Ann. Neurol. 22 1987 575 579
133. A. Plaitakis E. Constantakakis J. Smith The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis Ann. Neurol. 24 1988 446 449
134. J.H.M. Prehn K. Lippert J. Krieglstein Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury? Eur. J. Pharmacol. 292 1995 179 189
135. S. Przedborski V. Jackson-Lewis R. Yokoyama T. Shibata V.L. Dawson T.M. Dawson Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity Proc. Natl. Acad. Sci. USA 93 1996 4565 4571
136. R. Radi J.S. Beckman K.M. Bush B.A. Freeman Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide J. Biol. Chem. 266 1991 4244 4250
137. R.D. Randall S.A. Thayer Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons J. Neurosci. 12 1992 1882 1895
138. I.J. Reynolds T.G. Hastings Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation J. Neurosci. 15 1995 3318 3327
139. J. Rogers J.H. Morrison Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease J. Neurosci. 5 1985 2801 2808
140. D.R. Rosen T. Siddique D. Patterson D.A. Figlewicz P. Sapp A. Hentati D. Donaldson J. Goto J.P. O'Regan H.X. Deng Z. Rahmani A. Krizus D. McKenna-Yasek A. Cayabyab S.M. Gaston R. Berger R.E. Tanzi J.J. Halperin B. Herzfeldt Van R. der Bergh W.Y. Hung T. Bird G. Deng D.W. Mulder C. Smyth N.G. Laing E. Soriano M.A. Pericak-Vance J. Haines G.A. Rouleau J.S. Gusella H.R. Horvitz R.H. Brown Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59 62
141. S. Rothman Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death J. Neurosci. 4 1984 1884 1891
142. S.M. Rothman J.H. Thurston R.E. Hauhart Delayed neurotoxicity of excitatory amino acids in vitro Neuroscience 22 1987 471 480
143. J.D. Rothstein G. Tsai R.W. Kuncl L. Clawson D.R. Cornblath D.B. Drachman A. Pestronk B.L. Stauch J.T. Coyle Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis Ann. Neurol. 28 1990 18 25
144. J.D. Rothstein L.J. Martin R.W. Kuncl Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis N. Engl. J. Med. 326 1992 1464 1468
145. J.D. Rothstein L. Jin M. Dykes-Hoberg R.W. Kuncl Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity Proc. Natl. Acad. Sci. USA 90 1993 6591 6595
146. D.C. Rubinsztein J. Leggo M. Chiano A. Dodge G. Norbury E. Rosser D. Craufurd Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease Proc. Natl. Acad. Sci. USA 94 1997 3872 3876
147. K. Sakurada M. Masu S. Nakanishi Alteration of Ca2+ permeability and sensitivity to Mg2+ and channel blockers by a single amino acid substitution in the N -methyl-D-aspartate receptor J. Biol. Chem. 268 1993 410 415
148. J. Sánchez-Prieto D.C. Budd I. Herrero E. Vázquez D.G. Nicholls Presynaptic receptors and the control of glutamate exocytosis Trends Neurol. Sci. 19 1996 235 239
149. J.B. Schulz D.R. Henshaw B.G. Jenkins R.J. Ferrante N.W. Kowall B.R. Rosen M.F. Beal 3-acetylpyridine produces age-dependent excitotoxic lesions in rat striatum J. Cereb. Blood Flow Metab. 14 1994 1024 1029
150. J.B. Schulz D.R. Henshaw D. Siwek B.G. Jenkins R.J. Ferrante P.B. Cipolloni N.W. Kowall B.R. Rosen M.F. Beal Involvement of free radicals in excitotoxicity in vivo J. Neurochem. 64 1995 2239 2247
151. J.B. Schulz R.T. Matthews B.G. Jenkins R.J. Ferrante D. Siwek D.R. Henshaw P.B. Cipolloni P. Mecocci N.W. Kowall B.R. Rosen M.F. Beal Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo J. Neurosci. 15 1995 8419 8429
152. J.B. Schulz R.T. Matthews M.M.K. Muqit S.E. Browne M.F. Beal Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice J. Neurochem. 64 1995 936 939
153. J.B. Schulz R.T. Matthews B.G. Jenkins P. Brar M.F. Beal Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trap J. Cereb. Blood Flow Metab. 15 1995 948 952
154. J.B. Schulz R.T. Matthews D.R. Henshaw M.F. Beal Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases Neuroscience 71 1996 1043 1048
155. J.B. Schulz D.R. Henshaw U. MacGarvey M.F. Beal Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity Neurochem. Int. 29 1996 167 171
156. R. Schwarcz W.O. Whetsell Jr. R.M. Mangano Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain Science 219 1983 316 318
157. P.J. Shaw R.M. Chinnery P.G. Ince Non-NMDA receptors in motor neuron disease (MND): A quantitative autoradiographic study in spinal cord and motor cortex using [3H]CNQX and [3H]kainate Brain Res. 655 1994 186 194
158. S. Shimohama N. Ogawa Y. Tamura A. Akaike T. Tsukahara H. Iwata J. Kimura Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons Brain Res. 632 1993 296 302
159. P.K. Sonsalla G.D. Zeevalk L. Manzino A. Giovanni W.J. Nicklas MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats J. Neurochem. 58 1992 1979 1982
160. P.S. Spencer C.N. Allen G.E. Kisby A.C. Ludolph S.M. Ross D.N. Roy Lathyrism and western Pacific amyotrophic lateral sclerosis: Etiology of short and long latency motor system disorders Adv. Neurol. 56 1991 287 299
161. J. Stadler T.R. Billiar R.D. Curran D.J. Stuehr J.B. Ochoa R.L. Simmons Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes Am. J. Physiol. 260 1991 C910 C916
162. E. Storey B.T. Hyman B.G. Jenkins E. Brouillet J.M. Miller B.R. Rosen M.F. Beal 1-methyl-4-phenyl-pyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism J. Neurochem. 58 1992 1975 1978
163. N.J. Sucher M. Awobuluyi Y.B. Choi S.A. Lipton NMDA receptors: From genes to channels Trends Pharmacol. Sci. 17 1996 348 355
164. A. Tomac E. Lindqvist L.F.H. Lin S.O. Ögren D. Young B.J. Hoffer L. Olson Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo Nature 373 1995 335 339
165. L. Turski K. Bressler K.J. Rettig P.A. Löschmann H. Wachtel Protection of substantia nigra from MPP+ neurotoxicity by N -methyl-D-aspartate antagonists Nature 349 1991 414 418
166. L. Turski H. Ikonomidou Striatal toxicity of 3-nitropropionic acid prevented by the AMPA antagonist NBQX Soc. Neurosci. Abst. 20 1994 1677
167. M. Tymianski M.P. Charlton P.L. Carlen C.H. Tator Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons J. Neurosci. 13 1993 2085 2104
168. M. Tymianski M.C. Wallace I. Spigelman M. Uno P.L. Carlen C.H. Tator M.P. Charlton Cell-permeant Ca2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo Neuron 11 1993 221 235
169. R.J. Uitti A.H. Rajput J.E. Ahlskog K.P. Offord M.M. Ho M. Prasad A. Rajput P. Basran Amantadine treatment is an independent predictor of improved survival in parkinsonism Can. J. Neurol. Sci. 20 1993 S235
170. J. Ulas L.C. Brunner J.W. Geddes W. Choe C.W. Cotman N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease Neuroscience 49 1992 45 61
171. T.A. Verdoorn N. Burnashev H. Monyer P.H. Seeburg B. Sakmann Structural determinants of ion flow through recombinant glutamate receptor channels Science 252 1991 1715 1718
172. H.J. Waldvogel R.L.M. Faull M.N. Williams M. Dragunow Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins Brain Res. 546 1991 329 335
173. R.A. Wallis K.L. Panizzon D. Henry C.G. Wasterlain Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation Neuroreport 5 1993 245 248
174. G.J. Wang R.D. Randall S.A. Thayer Glutamate-induced intracellular acidification of cultured hippocampal neurons demonstrates altered energy metabolism resulting from Ca2+ loads J. Neurophysiol. 72 1994 2563 2569
175. J.C. Watkins P. Krogsgaard-Larsen Honoré T. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists Trends Pharmacol. Sci. 11 1990 25 33
176. M. Weller S.M. Paul 3-nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons Eur. J. Pharmacol. 248 1993 223 228
177. P. Werner M. Voight K. Keinänen W. Wisden P.H. Seeburg Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells Nature 351 1991 742 744
178. R.J. White I.J. Reynolds Mitochondria and Na+ /Ca2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons J. Neurosci. 15 1995 1318 1328
179. M.R. Witt K. Dekermendjian A. Frandsen A. Schousboe M. Nielsen Complex correlation between excitatory amino acid-induced increase in the intracellular Ca2+ concentration and subsequent loss of neuronal function in individual neocortical neurons in culture Proc. Natl. Acad. Sci. USA 91 1994 12303 12307
180. U. Wüllner A.B. Young J.B. Penney M.F. Beal 3-nitropropionic acid toxicity in the striatum J. Neurochem. 63 1994 1772 1781
181. A.B. Young J.T. Greenamyre Z. Hollingsworth R. Albin C. D'Amato I. Shoulson J.B. Penney NMDA receptor losses in putamen from patients with Huntington's disease Science 241 1988 981 983
182. A.B. Young G.E. Fagg Excitatory amino acid receptors in the brain: Membrane binding and receptor autoradiographic approaches Trends Pharmacol. Sci. 11 1990 126 133
183. G.D. Zeevalk W.J. Nicklas Chemically induced hypoglycemia and anoxia: Relationship to glutamate receptor-mediated toxicity in retina J. Pharmacol. Exp. Ther. 253 1990 1285 1292
184. G.D. Zeevalk W.J. Nicklas Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition J. Pharmacol. Exp. Ther. 257 1991 870 878
185. J. Zhang V.L. Dawson T.M. Dawson S.H. Snyder Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity Science 263 1994 687 689
186. W.C. Zinkand R.J. Stumpo C. Thompson J. Patel L.M. Pullan Lack of involvement of nitric oxide in NMDA-induced neuronal cell death in cortical culture Neuroreport 5 1993 148 150
187. F. Zipp H. Baas P.A. Fischer Lamotrigineantiparkinsonian activity by blockade of glutamate release? J. Neural Transm. Park. Dis. Dement. Sect. 5 1993 67 75
188. A. Zuddas G. Oberto Vaglini F.F. Fascetti F. Fornai G.U. Corsini MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates J. Neurochem. 59 1992 733 739